- Corporate Officers - M
- Manning Paul B
Insider Trading History of Manning Paul B
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Manning Paul B since 2016.
This trader's CIK number is 1494695.
At the time of last reporting, Manning Paul B was the Officer of Liquidia Corp. (stock ticker symbol LQDA).
Also see all insider trading activities at Liquidia Corp.
Note that in the past
Manning Paul B also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Avexis, Inc. (AVXS) by Manning Paul B
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | AVXS | 0 | $0 | 289,855 | $9,999,997 | 0 | $0 |
Yearly summary of insider trading at Taysha Gene Therapies, Inc. (TSHA) by Manning Paul B
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | TSHA | 750,000 | $2,062,500 | 0 | $0 | 0 | $0 |
| 2024 | TSHA | 1,333,333 | $2,999,999 | 0 | $0 | 0 | $0 |
| 2023 | TSHA | 16,566,667 | $14,983,000 | 0 | $0 | 0 | $0 |
| 2022 | TSHA | 1,701,602 | $4,571,809 | 0 | $0 | 0 | $0 |
| 2021 | TSHA | 22,202 | $279,843 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Liquidia Corp (LQDA) by Manning Paul B
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | LQDA | 0 | $0 | 670,837 | $18,999,728 | 0 | $0 |
| 2024 | LQDA | 337,078 | $2,999,994 | 0 | $0 | 0 | $0 |
| 2023 | LQDA | 279,330 | $2,000,002 | 0 | $0 | 0 | $0 |
| 2022 | LQDA | 392,156 | $1,999,995 | 0 | $0 | 0 | $0 |
| 2021 | LQDA | 198,413 | $500,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Acumen Pharmaceuticals, Inc. (ABOS) by Manning Paul B
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | ABOS | 312,500 | $5,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Candel Therapeutics, Inc. (CADL) by Manning Paul B
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | CADL | 1,250,000 | $7,500,000 | 0 | $0 | 0 | $0 |
| 2021 | CADL | 56,000 | $410,792 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Verrica Pharmaceuticals Inc. (VRCA) by Manning Paul B
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | VRCA | 22,921,348 | $0 | 0 | $0 | 0 | $0 |
| 2023 | VRCA | 200,000 | $1,003,999 | 0 | $0 | 0 | $0 |
| 2022 | VRCA | 4,761,904 | $9,999,998 | 0 | $0 | 0 | $0 |
| 2021 | VRCA | 789,830 | $11,380,396 | 0 | $0 | 0 | $0 |
| 2020 | VRCA | 194,500 | $1,329,805 | 0 | $0 | 0 | $0 |
| 2019 | VRCA | 68,386 | $837,836 | 0 | $0 | 0 | $0 |
| 2018 | VRCA | 403,200 | $6,002,223 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Dova Pharmaceuticals Inc. (DOVA) by Manning Paul B
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | DOVA | 96,062 | $953,983 | 0 | $0 | 0 | $0 |
| 2018 | DOVA | 542,131 | $6,419,458 | 0 | $0 | 0 | $0 |
Insider trading activities at 7 companies by Manning Paul B:
1. Avexis, Inc. (AVXS)
2. Taysha Gene Therapies, Inc. (TSHA)
3. Liquidia Corp (LQDA)
4. Acumen Pharmaceuticals, Inc. (ABOS)
5. Candel Therapeutics, Inc. (CADL)
6. Verrica Pharmaceuticals Inc. (VRCA)
7. Dova Pharmaceuticals Inc. (DOVA)
Table 1. Insider trading of Avexis, Inc. (AVXS) by Manning Paul B
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-09-13 | AVXS | Sale | 289,855 | 34.50 | 9,999,997 |
Table 2. Insider trading of Taysha Gene Therapies, Inc. (TSHA) by Manning Paul B
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-05-30 | TSHA | Buy | 750,000 | 2.75 | 2,062,500 |
| 2024-06-27 | TSHA | Buy | 1,333,333 | 2.25 | 2,999,999 |
| 2023-11-17 | TSHA | Buy | 100,000 | 1.63 | 163,000 |
| 2023-08-16 | TSHA | Buy | 16,466,667 | .90 | 14,820,000 |
| 2022-10-31 | TSHA | Buy | 1,500,000 | 2.00 | 3,000,000 |
| 2022-02-02 | TSHA | Buy | 125,000 | 7.77 | 971,250 |
| 2022-02-03 | TSHA | Buy | 76,602 | 7.84 | 600,559 |
| 2021-11-24 | TSHA | Buy | 2,202 | 13.19 | 29,044 |
| 2021-11-23 | TSHA | Buy | 20,000 | 12.54 | 250,799 |
Table 3. Insider trading of Liquidia Corp (LQDA) by Manning Paul B
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-08-28 | LQDA | Sale | 154,337 | 27.94 | 4,312,175 |
| 2025-08-29 | LQDA | Sale | 188,232 | 27.62 | 5,198,967 |
| 2025-09-02 | LQDA | Sale | 328,268 | 28.91 | 9,488,586 |
| 2024-09-12 | LQDA | Buy | 337,078 | 8.90 | 2,999,994 |
| 2023-12-14 | LQDA | Buy | 279,330 | 7.16 | 2,000,002 |
| 2022-04-18 | LQDA | Buy | 392,156 | 5.10 | 1,999,995 |
| 2021-04-13 | LQDA | Buy | 198,413 | 2.52 | 500,000 |
Table 4. Insider trading of Acumen Pharmaceuticals, Inc. (ABOS) by Manning Paul B
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-07-06 | ABOS | Buy | 312,500 | 16.00 | 5,000,000 |
Table 5. Insider trading of Candel Therapeutics, Inc. (CADL) by Manning Paul B
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-12-16 | CADL | Buy | 1,250,000 | 6.00 | 7,500,000 |
| 2021-07-27 | CADL | Buy | 36,000 | 7.36 | 264,852 |
| 2021-07-29 | CADL | Buy | 20,000 | 7.30 | 145,940 |
Table 6. Insider trading of Verrica Pharmaceuticals Inc. (VRCA) by Manning Paul B
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-11-22 | VRCA | Buy | 22,921,348 | .00 | 0 |
| 2023-07-24 | VRCA | Buy | 200,000 | 5.02 | 1,003,999 |
| 2022-07-05 | VRCA | Buy | 4,761,904 | 2.10 | 9,999,998 |
| 2021-12-02 | VRCA | Buy | 30,023 | 9.45 | 283,717 |
| 2021-12-03 | VRCA | Buy | 19,977 | 9.22 | 184,187 |
| 2021-03-25 | VRCA | Buy | 739,830 | 14.75 | 10,912,492 |
| 2020-08-20 | VRCA | Buy | 20,000 | 9.09 | 181,800 |
| 2020-08-18 | VRCA | Buy | 10,000 | 8.55 | 85,500 |
| 2020-08-17 | VRCA | Buy | 6,000 | 6.92 | 41,520 |
| 2020-08-13 | VRCA | Buy | 108,500 | 6.41 | 695,485 |
| 2020-08-14 | VRCA | Buy | 50,000 | 6.51 | 325,500 |
| 2019-10-08 | VRCA | Buy | 5,208 | 14.02 | 73,016 |
| 2019-10-09 | VRCA | Buy | 8,778 | 14.06 | 123,418 |
| 2019-10-10 | VRCA | Buy | 6,900 | 15.05 | 103,845 |
| 2019-01-07 | VRCA | Buy | 47,500 | 11.32 | 537,557 |
| 2018-11-12 | VRCA | Buy | 30,200 | 13.56 | 409,663 |
| 2018-11-13 | VRCA | Buy | 40,000 | 14.87 | 594,920 |
| 2018-06-19 | VRCA | Buy | 300,000 | 15.00 | 4,500,000 |
| 2018-08-10 | VRCA | Buy | 33,000 | 15.08 | 497,640 |
Table 7. Insider trading of Dova Pharmaceuticals Inc. (DOVA) by Manning Paul B
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-08-09 | DOVA | Buy | 28,062 | 15.87 | 445,343 |
| 2019-03-07 | DOVA | Buy | 68,000 | 7.48 | 508,640 |
| 2018-12-21 | DOVA | Buy | 128,500 | 6.77 | 869,945 |
| 2018-12-20 | DOVA | Buy | 266,631 | 6.17 | 1,645,113 |
| 2018-06-06 | DOVA | Buy | 17,000 | 28.85 | 490,450 |
| 2018-06-07 | DOVA | Buy | 10,000 | 27.77 | 277,750 |
| 2018-06-04 | DOVA | Buy | 20,000 | 24.39 | 487,700 |
| 2018-06-05 | DOVA | Buy | 100,000 | 26.48 | 2,648,500 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Manning Paul B
(Officer of Liquidia Corp at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.